Genomics

Dataset Information

0

Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome

ABSTRACT: Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome

PROVIDER: PRJNA1270094 | ENA |

REPOSITORIES: ENA

Json Xml

Similar Datasets

Genomics NCTN: Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome (AAML1531)
| PRJNA1270095 | ENA
Genomics NCTN: Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma
| PRJNA1288585 | ENA
Genomics NCTN: Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma
| PRJNA1288586 | ENA
Genomics NCTN: Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
| PRJNA1288589 | ENA
Genomics NCTN: Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
| PRJNA1288590 | ENA
Genomics Down Syndrome
| PRJNA804910 | ENA
Genomics NCTN: Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
| PRJNA1288587 | ENA
Genomics NCTN: Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
| PRJNA1288588 | ENA
Genomics NCTN: Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
| PRJNA1288575 | ENA
Genomics NCTN: Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
| PRJNA1288576 | ENA